CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in a small pilot trial involving patients with lymphoma of the brain and/or spinal cord, Dana-Farber Cancer Institute ...
Dec 11, 2022
0
47
